Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-23
1993-06-29
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514411, 514381, 514382, 514406, 514256, 514269, 514274, 514307, 514309, 514310, 514311, 514312, 514313, 514314, 514259, 514260, 514249, 514248, 514365, 514369, 514370, 514367, 514372, 514373, 514374, 514376, 514377, 514375, 514378, 514380, 514397, 514394, 514395, 5142328, 514323, 514253, 514254, 544372, 544142, 544237, 544235, 544353, 544354, 544355, 544356, 544284, 544298, 544333, 544322, 544405, 544238, 548439, 548449, 548448, 548450, 548451, 548252, 548253, 548251, 548181, 548159, 548214, 548207, 548212,
Patent
active
052235173
ABSTRACT:
Heterocyclically substituted cycloalkano[b]-indolesulphonamides can be prepared by reaction of appropriate N-unsubstituted indoles with acrylonitrile, followed by hydrolysis, esterification or amidation, or by reaction of heterocyclically substituted hydrazines with cycloalkanones or by subsequent introduction of the heterocyclic group into appropriate indole derivatives. The heterocyclically substituted cycloalkano[b]-indolesulphonamides can be employed for the treatment of thromboembolic disorders, ischaemias, arteriosclerosis, asthma, allergies and for the prophylaxis of myocardial infarcts.
REFERENCES:
patent: 4988820 (1991-01-01), Boshagen et al.
Okawa et al., Chemical Abstracts vol. 69, Entry 37117u (1968).
Hahn et al., Chemical Abstracts, vol. 85, entry 94224f (1976).
Boeshagen et al., Chemical Abstracts, vol. 109, entry 230800j (1988).
Bischoff Erwin
Dellweg Hans-Georg
Muller Ulrich E.
Niewohner Ulrich
Perzborn Elisabeth
Bayer Aktiengesellschaft
Ford John M.
LandOfFree
Heterocyclically substituted cycloalkano[b]-indolesulphonamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclically substituted cycloalkano[b]-indolesulphonamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclically substituted cycloalkano[b]-indolesulphonamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755703